$2.57
-0.04-1.53%
At close: Dec 17, 4:00 PM EST
$2.50
-0.07-2.72%
After Hours: 7:57 AM EST
Comments
Loading...
Silexion Therapeutics Analyst Ratings and Price Targets | NASDAQ:SLXN | Benzinga
Silexion Therapeutics Corp has a consensus price target of $5.5 based on the ratings of 2 analysts. The high is $6 issued by Litchfield Hills on December 15, 2025. The low is $5 issued by Maxim Group on March 20, 2025. The 3 most-recent analyst ratings were released by Litchfield Hills, Maxim Group, and Maxim Group on December 15, 2025, March 20, 2025, and November 1, 2024, respectively. With an average price target of $4 between Litchfield Hills, Maxim Group, and Maxim Group, there's an implied 60.00% upside for Silexion Therapeutics Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Litchfield Hills
Maxim Group
1calculated from analyst ratings
Analyst Ratings for Silexion Therapeutics
FAQ
What is the target price for Silexion Therapeutics (SLXN) stock?
The latest price target for Silexion Therapeutics (NASDAQ:SLXN) was reported by Litchfield Hills on December 15, 2025. The analyst firm set a price target for $6.00 expecting SLXN to rise to within 12 months (a possible 140.00% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Silexion Therapeutics (SLXN)?
The latest analyst rating for Silexion Therapeutics (NASDAQ:SLXN) was provided by Litchfield Hills, and Silexion Therapeutics initiated their buy rating.
When was the last upgrade for Silexion Therapeutics (SLXN)?
There is no last upgrade for Silexion Therapeutics
When was the last downgrade for Silexion Therapeutics (SLXN)?
There is no last downgrade for Silexion Therapeutics.
When is the next analyst rating going to be posted or updated for Silexion Therapeutics (SLXN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Silexion Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Silexion Therapeutics was filed on December 15, 2025 so you should expect the next rating to be made available sometime around December 15, 2026.
Is the Analyst Rating Silexion Therapeutics (SLXN) correct?
While ratings are subjective and will change, the latest Silexion Therapeutics (SLXN) rating was a initiated with a price target of $0.00 to $6.00. The current price Silexion Therapeutics (SLXN) is trading at is $2.50, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
